Seven-Year Visual and Anatomical Outcomes of Intravitreal Vascular Endothelial Growth Factor Inhibition for Neovascular Age-Related Macular Degeneration

Figure 3

Mean change of central macular thickness for all eyes measured by spectral domain-optical coherence tomography B-scans over time.